By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
| Currency | US Dollars |
| Share Price | $ 131.14 |
| Change Today | $ 2.03 |
| % Change | 1.57 % |
| 52 Week High | $133.10 |
| 52 Week Low | $92.92 |
| Volume | 8,549,820 |
| Shares Issued | 1,246.00m |
| Market Cap | $163,400m |
| RiskGrade | 120 |
| Strong Buy | 10 |
| Buy | 13 |
| Neutral | 5 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 29 |

| Time | Volume / Share Price |
| 16:00 | 1,456,679 @ $131.14 |
| 15:59 | 100 @ $131.14 |
| 15:59 | 130 @ $131.14 |
| 15:59 | 238 @ $131.14 |
| 15:59 | 200 @ $131.14 |
You are here: research